Parameter | Score |
GLUT1-positive | 2.83* |
GLUT1-negative | 0* |
Small tumor | 0* |
Large tumor | 1.95* |
SRC | 0* |
Non-SRC | 0.81* |
EGC | 0* |
AGC | 2.46* |
AGC, GLUT+ve, large, non-SRC | 8.05† |
AGC, GLUT–ve, large, non-SRC | 5.22† |
AGC, GLUT+ve, large, SRC | 7.24† |
AGC, GLUT–ve l, large, SRC | 4.41† |
AGC, GLUT+ve, small, non-SRC | 6.1† |
AGC, GLUT–ve, small, non-SRC | 3.27† |
EGC, GLUT+ve, large, non-SRC | 5.59† |
AGC, GLUT+ve, small, SRC | 5.29† |
EGC, GLUT–ve, large, non-SRC | 2.76† |
AGC, GLUT–ve, small, SRC | 2.46† |
EGC, GLUT+ve, large, SRC | 4.78† |
EGC, GLUT–ve, large, SRC | 1.95† |
EGC, GLUT+ve, small, non-SRC | 3.64† |
EGC, GLUT–ve, small, non-SRC | 0.81† |
EGC, GLUT+ve, small, SRC | 2.83† |
EGC, GLUT–ve, small, SRC | 0† |
↵* Log (odds ratio).
↵† Total score.
+ve = positive; –ve = negative.
Score was obtained from odds ratio of clinicopathologic parameters significantly associated with 18F-FDG avidity from systematic literature review. Sixteen different combinations of parameters including GLUT1 status with combined score ranging from 0 to 8.05 were used.